UFF
AGN

USA Financial Formulas’s Allergan plc AGN Stock Holding History

USA Financial Formulas’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,324
Closed -$692K – 295
2015
Q1 		$692K Buy
+2,324
New +$663K 0.23% 90

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

USA Financial Formulas's AGN Position: Q2 2015 in Review

USA Financial Formulas sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 2,324 shares — an estimated $692K sold.

USA Financial Formulas first reported a position in AGN in Q1 2015 and held it in 1 quarter. The position peaked at $692K in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • USA Financial Formulas reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • USA Financial Formulas sold 2,324 Allergan plc shares in Q2 2015, an estimated $692K.
  • USA Financial Formulas first reported a position in Allergan plc in Q1 2015 and held it in 1 quarter.
  • USA Financial Formulas's Allergan plc position peaked at $692K in Q1 2015.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on USA Financial Formulas's 13F filing for Q2 2015, filed 10 Aug 2015.